Skip to content

Catalyst Pharmaceutical CPRX Book value per share

Book value per share at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
-$2.19-1.7%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
$4.60+1.9%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$7.23+58.3%
Scholar Rock logo
Scholar RockSRRK
$2.17-22.3%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$0.14+66.0%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$1.81+502%

Other financials

Income statement

See full
Revenue$149.4M+5.6%
Gross profit$134.9M+9.2%
Operating income$73.2M+15.6%
Net income$63.7M+12.3%
EPS (diluted)$0.50+11.1%

Balance sheet

See full
Cash & equivalents$755.9M+30.2%
Total debt$2.7M-13.3%
Total equity$1.0B+27.5%
Total assets$1.1B+26.3%

Cash flow

See full
Operating cash flow$59.6M-0.8%
CapEx$27.0K
Free cash flow$59.6M-0.8%

Valuation

See full
Market cap$3.84B+2.7%
Enterprise value$3.09B-4.1%
P/E17.4×-1.6×
P/S6.4×-0.6×

Profitability

See full
Gross margin86%-0.2pp
Operating margin44.8%+1.6pp
Net margin37.1%+0.2pp
FCF margin34.9%-15.2pp

Returns & leverage

See full
Return on equity24.5%-4.6pp
Debt / equity0.0×
Current ratio7.1×+1.0×

Where this comes from

Calculated from Catalyst Pharmaceutical’s reported figures.

Based on the most recent quarter.

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Catalyst Pharmaceutical's book value per share?
Catalyst Pharmaceutical (CPRX) reported book value per share of $7.98 in Q1 2026.
How has Catalyst Pharmaceutical's book value per share changed year-over-year?
Catalyst Pharmaceutical's book value per share increased by 27.6% year-over-year, from $6.26 to $7.98.
What is the long-term trend for Catalyst Pharmaceutical's book value per share?
Over 5 years (2020 to 2025), Catalyst Pharmaceutical's book value per share has grown at a 36.3% compound annual growth rate (CAGR), from $1.60 to $7.50.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.